For the tenth consecutive year, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance.
The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios.
Roche has maintained its leadership through its excellent sustainability strategy, which is fully embedded in the company’s business and culture. “We are proud of being recognised once again for our sustainability efforts,” says Roche CEO Severin Schwan.
“Our most important contribution to society is the development of medicines and diagnostics that significantly improve people’s lives.
Open and constructive dialogue with other companies, universities, doctors and patients plays an essential role here in understanding the needs of our partners in the healthcare sector and enabling us to work together to develop more targeted medical solutions faster.”
Sustainability at Roche
For over 120 years, sustainability has been an integral part of Roche’s business. Roche follows a holistic approach when managing sustainability:
In addition to improving access to roducts, the company’s strategy also focuses on achieving continuous progress in areas such as social responsibility, environmental protection, supply chain sustainability, people attraction and retention.
